Literature DB >> 20425067

When are type 1 diabetic patients at risk for cardiovascular disease?

Trevor J Orchard1, Tina Costacou.   

Abstract

This discussion of increased cardiovascular risk in patients with type 1 diabetes reviews recent data concerning glycemia and the role of glycemic control in type 1 diabetes, as well as observations of an association with haptoglobin genotype and coronary artery disease events. This genetic predisposition also leads to oxidative damage and appears to be associated with profound high-density lipoprotein dysfunction. This article also briefly discusses recent data on general cardiovascular risk factors and provides updated comments concerning the association of coronary artery disease with other diabetes complications, especially renal disease.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20425067     DOI： 10.1007/s11892-009-0089-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  51 in total

1.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors:  Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

2.  Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.

Authors:  Mahmoud Suleiman; Doron Aronson; Rabea Asleh; Michael R Kapeliovich; Ariel Roguin; Simcha R Meisel; Michael Shochat; Abeer Sulieman; Shimon A Reisner; Walter Markiewicz; Haim Hammerman; Rachel Lotan; Nina S Levy; Andrew P Levy
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

3.  Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus.

Authors:  Janet K Snell-Bergeon; Dana Dabelea; Lorraine G Ogden; John E Hokanson; Gregory L Kinney; James Ehrlich; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

4.  Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Authors:  Maria Lajer; Lise Tarnow; Anders Jorsal; Tom Teerlink; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2007-12-27       Impact factor: 19.112

5.  Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association.

Authors:  John P Bantle; Judith Wylie-Rosett; Ann L Albright; Caroline M Apovian; Nathaniel G Clark; Marion J Franz; Byron J Hoogwerf; Alice H Lichtenstein; Elizabeth Mayer-Davis; Arshag D Mooradian; Madelyn L Wheeler
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

6.  Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease.

Authors:  Janet K Snell-Bergeon; David M Maahs; Lorraine G Ogden; Gregory L Kinney; John E Hokanson; Eric Schiffer; Marian Rewers; Harald Mischak
Journal:  Diabetes Technol Ther       Date:  2009-01       Impact factor: 6.118

7.  Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes.

Authors:  Silvie Lacigova; Lubos Bartunek; Daniela Cechurova; Jakub Visek; Jitka Gruberova; Michal Krcma; Zdenek Jankovec; Zdenek Rusavy; Michal Zourek
Journal:  Diabetes Res Clin Pract       Date:  2008-11-14       Impact factor: 5.602

8.  Effects of a diet higher in carbohydrate/lower in fat versus lower in carbohydrate/higher in monounsaturated fat on postmeal triglyceride concentrations and other cardiovascular risk factors in type 1 diabetes.

Authors:  Irene Strychar; Jeffrey S Cohn; Geneviève Renier; Michèle Rivard; Nahla Aris-Jilwan; Hugues Beauregard; Sara Meltzer; André Bélanger; Richard Dumas; Alain Ishac; Farouk Radwan; Jean-François Yale
Journal:  Diabetes Care       Date:  2009-06-18       Impact factor: 19.112

9.  Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

Authors:  Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461

10.  Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

Authors:  Sabita S Soedamah-Muthu; Nish Chaturvedi; Daniel R Witte; Lynda K Stevens; Massimo Porta; John H Fuller
Journal:  Diabetes Care       Date:  2008-03-28       Impact factor: 19.112
View more
  17 in total

1.  Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.

Authors: 
Journal:  Diabetes Care       Date:  2016-02-09       Impact factor: 19.112

2.  Risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes.

Authors:  Rachel G Miller; Trevor J Orchard; Tina Costacou
Journal:  Diabetes Res Clin Pract       Date:  2020-04-08       Impact factor: 5.602

Review 3.  Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?

Authors:  Uyen T Truong; David M Maahs; Stephen R Daniels
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

4.  Hemoglobin A1c Level and Cardiovascular Disease Incidence in Persons With Type 1 Diabetes: An Application of Joint Modeling of Longitudinal and Time-to-Event Data in the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

5.  Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2016-04-21       Impact factor: 3.291

6.  Naringenin alleviates myocardial ischemia reperfusion injury by enhancing the myocardial miR-126-PI3K/AKT axis in streptozotocin-induced diabetic rats.

Authors:  Shang-Hai Li; Ming-Shuang Wang; Wei-Liang Ke; Ming-Rui Wang
Journal:  Exp Ther Med       Date:  2021-05-27       Impact factor: 2.447

Review 7.  Glucose Management and the Sex Difference in Excess Cardiovascular Disease Risk in Long-Duration Type 1 Diabetes.

Authors:  Rachel G Miller; Tina Costacou
Journal:  Curr Diab Rep       Date:  2019-11-21       Impact factor: 4.810

8.  Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.

Authors:  Yi He; Graziella E Ronsein; Chongren Tang; Gail P Jarvik; W Sean Davidson; Vishal Kothari; Hyun D Song; Jere P Segrest; Karin E Bornfeldt; Jay W Heinecke
Journal:  Circ Res       Date:  2020-08-21       Impact factor: 17.367

9.  Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes.

Authors:  Antonio Ceriello; Anna Novials; Emilio Ortega; Silvia Canivell; Gemma Pujadas; Lucia La Sala; Loredana Bucciarelli; Maurizio Rondinelli; Stefano Genovese
Journal:  Cardiovasc Diabetol       Date:  2013-06-27       Impact factor: 9.951

10.  Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.

Authors:  Antonio Ceriello; Anna Novials; Emilio Ortega; Silvia Canivell; Lucia La Sala; Gemma Pujadas; Katherine Esposito; Dario Giugliano; Stefano Genovese
Journal:  Diabetes Care       Date:  2013-04-05       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.